Flashback Foreword: Gemcitabine/Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Transitional Cell Carcinoma. Small EJ. J Clin Oncol 2023;41:3879-3880.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Small EJ. Flashback Foreword: Gemcitabine/Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Transitional Cell Carcinoma. J Clin Oncol 2023;41:3879-3880.
PMID: 37549481